Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial

• Monique Wasunna ,

  * E-mail: africa@dndi.org

  Affiliations Drugs for Neglected Diseases initiative, Nairobi, Kenya, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya

  ⨯
• Simon Njenga,

  Affiliation Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya

  ⨯
• Manica Balasegaram,

  Current address: Médecins Sans Frontières, Switzerland

  Affiliation Drugs for Neglected Diseases initiative, Geneva, Switzerland

  ⨯
• Neal Alexander,

  Affiliation MRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, United Kingdom

  ⨯
• Raymond Omollo,

  Affiliation Drugs for Neglected Diseases initiative, Nairobi, Kenya

  ⨯
• Tansy Edwards,

  Affiliation MRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, United Kingdom

  ⨯
• Thomas P. C. Dorlo,

  Affiliation Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands

  ⨯
• Brima Musa,

  Affiliation Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan

  ⨯
• Mohammed Hassan Sharaf Ali,

  Affiliation Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan

  ⨯
• Mohammed Yasein Elamin,

  Affiliation Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan

  ⨯
• George Kirigi,

  Affiliation Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya

  ⨯
• Rashid Juma †,

  † Deceased.

  Affiliation Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya

  ⨯
• Anke E. Kip,

  Affiliations Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands, Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands

  ⨯
• Gerard J. Schoone,

  Affiliation KIT Biomedical Research, Amsterdam, the Netherlands

  ⨯
• Asrat Hailu,

  Affiliation College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia

  ⨯
• Joseph Olobo,

  Affiliation Department of Medical Microbiology, Leishmaniasis Unit, College of Health Sciences, Makerere University, Kampala, Uganda

  ⨯
• Sally Ellis,

  Affiliation Drugs for Neglected Diseases initiative, Geneva, Switzerland

  ⨯
• Robert Kimutai,

  Affiliations Drugs for Neglected Diseases initiative, Nairobi, Kenya, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya

  ⨯
• Susan Wells,

  Affiliation Drugs for Neglected Diseases initiative, Geneva, Switzerland

  ⨯
• Eltahir Awad Gasim Khalil,

  Affiliation Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan

  ⨯
• Nathalie Strub Wourgaft,

  Affiliation Drugs for Neglected Diseases initiative, Geneva, Switzerland

  ⨯
• Fabiana Alves,

  Affiliation Drugs for Neglected Diseases initiative, Geneva, Switzerland

  ⨯
•  [ ... ],
• Ahmed Musa

  Affiliation Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan

  ⨯
• [ view all ]
• [ view less ]